Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 6Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Tobacco Use Disorder 2Tobacco Smoking 1Substance-Related Disorders 1Smoking Cessation 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Specimen Handling 5Enoxaparin 5Carboplatin 5Bevacizumab 5Nivolumab 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2pembrolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Tobacco Use Cessation Devices × Clear all
NCT05515354 2026-03-19

MC-NRT

Centre for Addiction and Mental Health

Phase 4 Recruiting
1,200 enrolled

Tobacco Smoking, Tobacco Use Disorder, Smoking Cessation, Substance-Related Disorders

NCT07220356 2026-02-02

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

Johns Hopkins University

Phase 4 Recruiting
30 enrolled

Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡